June 12, 2025

Checkpoint Therapeutics, Inc. (CKPT) Stock Analysis: Navigating the Biotechnology Landscape with a 4.46% Potential Upside

Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) is making waves in the biotechnology sector as it navigates the complex landscape of cancer therapeutics. With a market capitalization of $370.71 million, this commercial-stage..

XOMA Royalty Corporation (XOMA) Stock Analysis: Exploring a 157% Potential Upside and Robust Dividend Yield

XOMA Royalty Corporation (NASDAQ: XOMA) is capturing the attention of investors with its unique position in the biotechnology sector and an attractive potential upside of 157.74%. With a core focus..

Mereo BioPharma (MREO) Stock Analysis: Exploring the 187.96% Upside Potential

Mereo BioPharma Group plc (NASDAQ: MREO) is drawing significant attention in investor circles, primarily due to its substantial potential upside of 187.96%. This UK-based biopharmaceutical company, with a market capitalization..

Benitec Biopharma Inc. (BNTC) Stock Analysis: Unpacking a 55% Potential Upside

Benitec Biopharma Inc. (NASDAQ: BNTC), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to genetic medicines. With a market capitalization of $434.71 million,..

Shopify Inc. (SHOP) Stock Analysis: Revenue Growth Soars with Robust 26.80% Increase

As Shopify Inc. (SHOP) continues to solidify its presence as a leading player in the technology sector, the company’s impressive revenue growth and strategic positioning offer individual investors a unique..

Abeona Therapeutics Inc. (ABEO) Stock Analysis: An Investor’s Insight into a Biotech with a 220% Upside Potential

Abeona Therapeutics Inc. (NASDAQ: ABEO) has caught the attention of the investment community with its promising potential upside of 220.40%, according to analyst ratings. This clinical-stage biopharmaceutical company specializes in..

Varex Imaging Corporation (VREX) Stock Analysis: A Potential 90% Upside in the Medical Devices Sector

Varex Imaging Corporation (NASDAQ: VREX), a key player in the healthcare sector, specifically within the medical devices industry, presents a compelling investment opportunity with a notable potential upside of 90.37%...

Fulcrum Therapeutics, Inc. (FULC): Investor Outlook with 10.86% Potential Upside

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) is increasingly capturing the attention of biotech investors with its promising pipeline and a notable potential upside of 10.86% as per recent analyst ratings. Positioned..

Quantum-Si Incorporated (QSI) Stock Analysis: Exploring a 60.98% Potential Upside in the Healthcare Sector

In the dynamic landscape of the healthcare industry, Quantum-Si Incorporated (NASDAQ: QSI) stands out as an innovative player in the medical devices sector. With a market capitalization of $322.96 million,..

AMTD Digital Inc. (HKD) Stock Analysis: Navigating Challenges Amidst the Digital Economy

AMTD Digital Inc. (HKD), a Paris-headquartered technology company, operates within the dynamic Software – Application industry. Despite its expansive reach across Europe, the United States, Hong Kong, Singapore, and Asia,..

Health Catalyst, Inc. (HCAT) Stock Analysis: A Promising 88% Potential Upside for Investors

Investors looking for a compelling opportunity in the healthcare sector may find Health Catalyst, Inc. (NASDAQ: HCAT) an intriguing prospect. With a market capitalization of $275.62 million, Health Catalyst operates..

Erasca, Inc. (ERAS) Stock Analysis: Exploring a Potential 280% Upside in Biotechnology

Erasca, Inc. (NASDAQ: ERAS) is making waves in the biotechnology sector, offering investors a compelling opportunity in the ever-evolving landscape of precision oncology. As a San Diego-based clinical-stage company, Erasca..

Palvella Therapeutics, Inc. (PVLA) Stock Analysis: A Lucrative Opportunity with 94% Upside Potential

For investors with an eye towards biotechnology, Palvella Therapeutics, Inc. (PVLA) represents a tantalizing opportunity in the healthcare sector. With its focus on rare genetic skin diseases, Palvella is at..

Viemed Healthcare, Inc. (VMD) Stock Analysis: Exploring a Potential 74% Upside

Viemed Healthcare, Inc. (NASDAQ: VMD) presents an intriguing opportunity for investors looking to delve into the healthcare sector, specifically within the niche of medical devices and respiratory healthcare services. Based..

Fair Isaac Corporation (FICO) Stock Analysis: Exploring a 21.69% Potential Upside for Investors

Fair Isaac Corporation (NYSE: FICO) is a behemoth in the technology sector with a remarkable market capitalization of $43.94 billion. Renowned for its pioneering role in analytics and digital decisioning..

Tvardi Therapeutics, Inc. (TVRD) Investor Outlook: A 93.55% Potential Upside in Biotechnology

Tvardi Therapeutics, Inc. (TVRD) is commanding attention in the biotechnology sector with a compelling narrative for investors. Based in Sugar Land, Texas, Tvardi is a biotechnology company focused on developing..

Neuronetics, Inc. (STIM) Investor Outlook: Unveiling a Compelling 78.88% Potential Upside

Neuronetics, Inc. (NASDAQ: STIM) is capturing the attention of the healthcare investment community with a promising potential upside of 78.88%. This medical device company, specializing in neurohealth treatments, is making..

Cidara Therapeutics (CDTX) Investor Outlook: A 61.97% Potential Upside in Biotech Innovation

Cidara Therapeutics, Inc. (CDTX), headquartered in San Diego, California, is a biotechnology company carving its niche in the healthcare sector by targeting serious diseases like cancer and invasive fungal infections...

Senseonics Holdings, Inc. (SENS): Investor Outlook with a 196.71% Potential Upside

Senseonics Holdings, Inc. (SENS), a pioneering entity in the healthcare sector, is drawing attention with its remarkable potential upside of 196.71%. Headquartered in Germantown, Maryland, Senseonics is a commercial-stage medical..

ClearPoint Neuro Inc. (CLPT): Investor Outlook with a Promising 125% Upside Potential

ClearPoint Neuro Inc. (NASDAQ: CLPT) is capturing the attention of investors with its innovative approach to medical devices in the healthcare sector, particularly in the realm of minimally invasive brain..

Search

Funds

June 12, 2025

Search

Funds

June 12, 2025

FTSE 100

Funds